<?xml version="1.0" encoding="UTF-8"?>
<p>Other clone-derived, rationally attenuated CHIKF vaccine candidates include strains with deletions of a large part of the nonstructural protein 3 (nsP3) gene or the entire 6K/TF gene [
 <xref rid="pntd.0006919.ref038" ref-type="bibr">38</xref>]. These vaccines, either administered as viral particles or infectious genomes launched from DNA, are highly immunogenic and efficacious in mice [
 <xref rid="pntd.0006919.ref038" ref-type="bibr">38</xref>]. The nsP3 deletion vaccine, Î”5nsP3 (VLA1553), is now in the recruitment stage for a Phase 1 clinical trial (
 <xref rid="pntd.0006919.t001" ref-type="table">Table 1</xref>).
</p>
